SeaStar Medical Holding Corporation

ICU Healthcare Biotechnology

SeaStar Medical Holding Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, up 814.1% from fiscal 2024. In the quarter to June 2026, revenue grew 82.0%, EPS grew 49.4% and free cash flow was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

2.90 0.16 −5.23%
Market cap
$13.5M
P/E
0.0×
Fwd P/E
−0.8×
Dividend yield
—
F-score
n/a
Altman Z
−16.12
Beneish M
5.00
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(356.87%) (302.01%) (295.15%) (290.37%)

+8 more TTM periods

ROA
(160.02%) (126.18%) (129.15%) (135.86%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(351.66%) (174.57%) (123.50%) (126.43%)
Average Days of Receivables
44.32 45.50 70.10 91.56
Free Cash Flow per Share
(3.35) (3.50) (6.56) (5.38)
Free Cash Flow
(13.69) (13.71) (13.60) (14.20)
Other line items

Show all line items

Columns are period end dates